💥 Fed cuts sparks mid cap boom! ProPicks AI scores with 4 stocks +23% each. Get October’s update first.Pick Stocks with AI

These Analysts Revise Their Forecasts On Eastman Chemical After Q1 Earnings

Published 29/04/2024, 14:01
© Reuters.  These Analysts Revise Their Forecasts On Eastman Chemical After Q1 Earnings
EMN
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

Eastman Chemical (NYSE:EMN) reported better-than-expected first-quarter earnings after the closing bell on Thursday.

Eastman Chemical posted adjusted earnings of $1.61 per share, beating market expectations of $1.43 per share. The company's quarterly sales came in at $2.310 billion versus estimates of $2.293 billion, according to data from Benzinga Pro.

“We delivered strong sequential earnings growth in the first quarter, above the high-end of our initial expectations,” said Mark Costa, Board Chair and CEO. “In the first quarter, we were encouraged to see continued evidence that inventory destocking is complete across most of our key end markets including consumer durables, building and construction, and personal care. Sales volume/mix improved 4 percent sequentially as demand for our products appears to be reconnecting to primary end-market demand. We are also incredibly proud to have achieved on spec production and revenue generation at our Kingsport methanolysis facility.”

Eastman Chemical affirmed FY2024 adjusted earnings guidance of $7.25 to $8.00 per share.

Eastman Chemical shares fell 0.6% to close at $95.56 on Friday.

These analysts made changes to their price targets on Eastman Chemical following earnings announcement.

  • B of A Securities cut the price target on Eastman Chemical from $113 to $112. B of A Securities analyst Steve Byrne maintained a Buy rating.
  • Jefferies increased the price target on Eastman Chemical from $102 to $125. Jefferies analyst Laurence Alexander upgraded the stock from Hold to Buy.
Now Check This Out: This Analyst With 86% Accuracy Rate Sees Around 13% Upside In Chipotle Mexican Grill – Here Are 5 Stock Picks For Last Week From Wall Street’s Most Accurate Analysts

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.